Home > Financial Ratios > NURECA

NURECA
Core EBITDA Growth

    Back to All Ratios
NURECA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NURECA
Please provide your vote to see the results

NURECA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 1,494.46103.88-112.51-1.79559.74

What is the latest Core EBITDA Growth ratio of NURECA ?

The latest Core EBITDA Growth ratio of NURECA is 1,494.46 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20251,494.46
Mar2024103.88
Mar2023-112.51
Mar2022-1.79
Mar2021559.74

How is Core EBITDA Growth of NURECA Trending?

Years Core EBITDA Growth % Change
Mar2025 1494.46
1,338.64
Mar2024 103.88
Positive
Mar2023 -112.51
Negative
Mar2022 -1.79
Negative
Mar2021 559.74 -

Other Financial Ratios of NURECA


Compare Core EBITDA Growth ratio of peers of NURECA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NURECA ₹257.3 Cr -10.3% -8.3% 2.5% Stock Analytics
POLY MEDICURE ₹21,638.6 Cr -5% -2.3% 3% Stock Analytics


NURECA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NURECA

-10.3%

-8.3%

2.5%

SENSEX

-1.1%

1%

3.4%


You may also like the below Video Courses